Dignitana
1.22
SEK
-0.81 %
DIGN
First North Stockholm
Medical Equipment & Services
Health Care
Less than 1K followers
-0.81%
-2.4%
+27.75%
-0.81%
-14.69%
-36.95%
-81.63%
-87.18%
-58.4%
Dignitana is active in medical technology. The company's main focus is to develop, manufacture, and distribute medical aids that are primarily used as a scalp cooling system in chemotherapy treatment, where the purpose is to eliminate or greatly reduce hair loss. The company operates worldwide. Dignitana was founded in 2007 has its headquarters located in Lund.
Read moreMarket cap
98.26M SEK
Turnover
60.28K SEK
Revenue
89.83M
EBIT %
-20.37 %
P/E
-
Dividend yield-%
-
Financial calendar
22/5
2025
General meeting '25
22/5
2025
Interim report Q1'25
21/8
2025
Interim report Q2'25
ShowingAll content types
Dignitana AB: Dignitana to address MedTech innovation at Texas BioLife Summit
Dignitana AB: Dignitana expands intellectual property with new patent in Korea
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools